MainBusinessMaterialsNanomaterials › Star Pharma

Star Pharma

Edit Page
Report
Scan day: 02 February 2014 UTC
20
Virus safety - good
Description: Develops dendrimer nanotechnology products for pharmaceutical, life-science and other applications.
Appendix 4C - Quarterly Cashflow Report Starpharma commences Dendrimer-Docetaxel clinical trial Starpharma to recoup additional $2 million for overseas R&D Cancer Australia funding for dendrimer-based lung treatment
Size: 223 chars

Contact Information

Email:
Phone&Fax:
Address:
Extended:

WEBSITE Info

Page title:Starpharma
Keywords:Starpharma Holdings Limited, dendrimer, Starpharma, VivaGel®, SPL7013, vaginal microbicide, sexually transmitted infections (STI), HIV, genital herpes, bacterial Vaginosis (BV), condom coating, Durex® condoms, sexual health, pharmaceutical, dendrimer drug delivery, drug targeting, drug solubilisation, diagnostics, pharmaceutical excipients, dendrimer, materials science, cosmetics, agrochemicals.
Description:
IP-address:27.131.71.131

WHOIS Info

NS
Name Server: NS61.WORLDNIC.COM
Name Server: NS62.WORLDNIC.COM
WHOIS
Status: clientTransferProhibited
Date
Creation Date: 31-mar-1999
Expiration Date: 31-mar-2015